Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations - PubMed
These results provide no evidence that clarithromycin is a likely major teratogen in humans. Use of claims data is one way to evaluate quickly and efficiently the safety of prescription medications in humans during pregnancy, especially when both exposure and outcome are rare.